Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive value of bronchodilator reversibility for 1-month indacaterol efficacy in moderate-to-severe COPD
2010-022831-12Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Oct 2010; status: completed.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-022831-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022831-12.